Active	Status	Sponsor type	Region	Phase	Filter
4 Active 2 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Cyclurad (cycloserine/lurasidone) / NRx Pharma, Alvogen
SBD-ASIB, NCT03396068: NRX-101 for Maintenance of Remission From Severe Bipolar Depression in Patients With Suicidal Ideation Oct 2021 - Dec 2021 : Data from the patients with acute suicidal ideation in severe bipolar depression	Active, not recruiting	3	72	US	NRX-101, Cyclurad, Lurasidone HCl	NeuroRx, Inc., Target Health Inc.	Bipolar Depression, Suicidal Ideation	12/24	12/24
MBD, NCT03395392: NRX-101 for Bipolar Depression With Subacute Suicidal Ideation	Completed	2/3	74	US	NRX-101, Lurasidone HCl, Latuda	NeuroRx, Inc., Prevail Infoworks, Inc	Bipolar Depression, Suicidal Ideation and Behavior	02/24	03/24
NCT06128213: NRX-101 for Complicated Urinary Tract Infection (UTI) Including Pyelonephritis	Not yet recruiting	2	13	NA	NRX101 (a fixed dose combination of D-cycloserine (DCS) and lurasidone HCl (lurasidone))	NeuroRx, Inc.	Urinary Tract Infections, Pyelonephritis	06/24	09/24
NRX-101 EA, NCT05779267: NRX-101 Expanded Access	Available	N/A		NA	NRX-101	NeuroRx, Inc., Prevail Infoworks	Bipolar Depression, Bipolar Affective Disorder